Journal of Critical Care
Volume 23, Issue 1 , Pages 2-4 , March 2008

Ventilator-associated pneumonia: Lessons learned from clinical trials

References 

  1. The Canadian Critical Care Trials G . A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med. 2006;355(25):2619–2630
  2. Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med. 2000;132(8):621–630
  3. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290(19):2588–2598
  4. Guidelines for the management of adults with hospital-aquired, ventilatior-associated, and healthcare-associated pneumonia. Am J Respin Crit Care Med. 2005;171(4):388–416
  5. Leibovici L, Paul M, Poznanski O, et al. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother. 1997;41(5):1127–1133
  6. Safdar N, Handelsman J, Maki DG. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis. 2004;4(8):519–527
  7. Garnacho-Montero J, Sa-Borges M, Sole-Violan J, et al. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy. Crit Care Med. 2007;35(8):1888–1895
  8. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165(7):867–903
  9. Parker CM, Kutsogiannis J, Muscedere J, et al. Ventilator-associated pneumonia caused by multidrug-resistant orgnisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes. J Crit Care. 2008;23(1):18–26
  10. Albert M, Friedrich JO, Adhikari NKJ, et al. Utility of Gram stain clinical management of suspected ventilator-associated pneumonia: secondary analysis of a multicenter randomized trial. J Crit Care. 2008;23(1):74–81
  11. Sanders KM, Adhikari NKJ, Friedrich JO, et al. Previous cultures are not clinically useful for going empiric antibiotics in suspected ventilator-associated pneumonia: secondary analysis from a randomized trial. J Crit Care. 2008;23(1):58–63
  12. Ruiz M, Torres A, Ewig S, et al. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. 2000;162(1):119-25.
  13. Sanchez-Nieto JM, Torres A, Garcia-Cordoba F, et al. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. Am J Respir Crit Care Med. 1998;157(2):371–376
  14. Sole Violan J, Fernandez JA, Benitez AB, Cardenosa Cendrero JA, Rodriguez de Castro F. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med. 2000;28(8):2737–2741
  15. Fagon JY, Chastre J. Management of suspected ventilator-associated pneumonia. Ann Intern Med. 2000;133(12):1009
  16. Kollef MH, Kollef KE. Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture results. Chest. 2005;128(4):2706–2713
  17. Bonten MJ, Bergmans DC, Stobberingh EE, et al. Implementation of bronchoscopic techniques in the diagnosis of ventilator-associated pneumonia to reduce antibiotic use. Am J Respir Crit Care Med. 1997;156(6):1820–1824
  18. Joffe AR, Muscedere J, Marshall JC, Su Y, Heyland DK. for the Canadian Critical Care Trials group. The safety of targeted antibiotic therapy for ventilator associated pneumonia: a multicenter observational study. J Crit Care. 2008;23(1):82–90
  19. Shorr AF, Cook D, Jiang X, Muscedere J, Heyland D. for the Canadian Critical Care Trials group. Correlates of clinical failure in ventilator-associated pneumonia: insights from a large, randomized trial. J Crit Care. 2008;23(1):64–73
  20. Luyt CE, Guerin V, Combes A, et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med. 2005;171(1):48–53
  21. Delisle M-S, Williamson DR, Perreault MM, Albert M, Jiang X, Heyland DK. The clinical significance of Candida colonization of respiratory tract secretions in critically ill patients. J Crit Care. 2008;23(1):11–17
  22. Azoulay E, Timsit JF, Tafflet M, et al. Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest. 2006;129(1):110–117
  23. Wunderink RG. Nosocomial pneumonia, including ventilator-associated pneumonia. Proc Am Thorac Soc. 2005;2(5):440–444
  24. Dodek P, Keenan S, Cook D, et al. Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med. 2004;141(4):305–313
  25. Muscedere J, Dodek P, Keenan S, et al. Comprehensive evidence based clinical practice guidelines for ventilator-associated pneumonia: prevention. J Crit Care. 2008;23(1):126–137
  26. Sinuff T, Muscedere J, Cook D, Dodek P, Heyland D. for the Canadian Critical Care Trials group. Ventilator-associated pneumonia: improving outcomes through guideline implementation. J Crit Care. 2008;23(1):118–125
  27. Baker AMMJ, Chang M, Dunagan D, Smith A, Haponik EF. Bronchoscopically guided management of ventilator-associated pneumonia in trauma patients. J Bronchol. 2003;10(1):7–16
  28. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000;162(2 Pt 1):505–511

PII: S0883-9441(08)00026-9

doi: 10.1016/j.jcrc.2007.12.020

Journal of Critical Care
Volume 23, Issue 1 , Pages 2-4 , March 2008

Article Tools